Oncology
The findings of a recent study identified microbiota signatures that may allow clinicians to predict the outcomes of CAR-T immunotherapy.
Microbiomepost discussed with Lorella Tripodi, University Federico II of Naples, about the research she is working with her colleagues.
Numerous evidences demonstrate the involvement of the sex hormone-gut microbiome axis in regulating the antitumor efficacy of ICIs.
The findings of a recent study suggest that tilimycin-producing bacteria can cause genetic mutations in the colon and increase a person’s susceptibility to disease.
The findings of a new study shed light on a general mechanism by which gut bacteria may influence anti-cancer immune responses.
The findings of a new study suggest that the microbial metabolite 3-IAA could help to treat PDAC.
Vaccines against F. nucleatum and other onco-microbes may help prevent diseases such as colorectal cancer.
The findings of a recent study tie the gut microbiota to immune surveillance of ovarian cancer and may inform new treatment approaches.
Fabio Grassi, Founder at MV BioTherapeutics SA, discussed how to understand the mechanisms of action for microbiome contributions to cancer therapeutic response in patients.
The findings of a new research suggest that dietary and antibacterial strategies may help to prevent neutropenia-related fever after cancer therapy.
